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Abstract: A simple and efficient protocol for the synthesis of novel indole-2-carboxylic acid 
analogues having aryl amine moieties (2a-k) has been described. The synthesized compounds were 
characterized by spectroscopic techniques (IR, 1H NMR, 13C NMR and MS-EI) and further screened 
for their antioxidant activity by using various in vitro assays such as 2,2-diphenyl-1-picrylhydrazyl 
(DPPH•) scavenging assay, 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS•+) radical 
scavenging activity, ferric reducing antioxidant power, cupric ion reducing ability method and 
phosphomolybdate method. In all the antioxidant assays performed, compounds 2b, 2d, 2e and 2f 
showed promising antioxidant activity. Whereas, compound 2c displayed potent antioxidant activity. 
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Introduction 
Reactive oxygen species (ROS) and free radicals have attracted increasing attention over the past 
decade. Free radicals are exacerbating factors in cellular injury and aging process1-3. 
Antioxidants, used to prevent or inhibit the natural phenomena of oxidation, have a broad 
application in diverse industrial fields as they have a huge importance either as industrial 
additives or health agents4,5. Research data have revealed that they could be suitable for 
preventive and therauptic purposes in several diseases related with oxidative stress (e.g. 
atherosclerosis, inflammatory injury, cancer and cardiovascular diseases)6,7. In the vast 
heterocyclic structural space, the indole nucleus occupies a position of major importance. Many 
indole derivatives including fused derivatives form the basis of a range of pharmaceuticals8,9. 
 Indole moiety occurs widely in synthetic and natural products containing an important 
class of therapeutic agents10,11. In the last decade,  antioxidant activity of synthetic indole  
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derivatives and their possible activity mechanisms have been widely studied11. Generally, 
pharmacophores containing typically the phenol moiety possess good antioxidant 
activity12. In addition to the traditional O–H bond type antioxidant, tricyclic amines 
having N–H bond functions as the antioxidant have attracted much research attention 
because aromatic amines (Ar2NH) have always been the central structure in many 
currently used drugs13. It was envisaged, that the two pharmacophores if linked together 
would generate novel molecular templates, which are likely to exhibit interesting 
antioxidant properties. Owing to the importance and in continuation of our work on 
synthesis of novel biologically active heterocyclic compounds14-17, in the present 
investigation we have focused on the synthesis and evaluation of antioxidant activity of 
novel indole-2-carboxylic acid analogues. Our study reveals that assembling of indole-2-
carboxylic acid with aryl amine moiety dispatch the generous support for the enhancement 
in the antioxidant activity. 
Experimental  
All the chemicals and reagents were purchased commercially from Merck, Himedia and SD 
Fine Chemicals and were used without further purification. Melting points of the 
synthesized compounds were determined in open capillaries and are uncorrected. Reactions 
are monitored by thin-layer chromatography (TLC) on silica gel 60 F254 aluminum sheets 
(Merck). IR spectra are recorded in KBr on FT-IR021 spectrophotometer (νmax in cm-1).           
1H NMR and 13C NMR on Jeol GSX 400-MHz spectrometer (chemical shift in δ ppm 
downfield from TMS as an internal reference). The mass spectra were recorded on Waters-
Q-TOF Ultima spectrometer. The elemental analysis was determined on FLASH EA-1112 
series instrument. All the compounds gave C, H, O and N analysis within ±0.4% of the 
theoretical values. 
Chemistry 
N-Acylation of indole-2-carboxylic acid with 2-chloroacetylchloride in the presence of 
triethylamine (TEA) as a base yields the key scaffold 1-(2-chloroacetyl)-1H-indole-2-
carboxylic acid (2) Scheme 1. Further, coupling of various aryl amines to key scaffold (2) by 
base condensation reaction affords novel indole-2-carboxylic acid analogues (2a-k) in 
moderate to good yield, which were identified by spectroscopic techniques: NMR (1H NMR, 
13C NMR), FT-IR and MS-EI. A typical synthetic strategy employed to obtain the title 
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Scheme 2. Pathway for the synthesis of indole-2-carboxylic acid-aryl amine conjugates (2a-k) 
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Procedure for the synthesis of 1-(2-chloroacetyl)-1H-indole-2-carboxylic acid 
(compound 2)  
To a well stirred solution of indole-2-carboxylic acid (1 mM) and triethylamine (1.2 mM) in 
10 mL dichloromethane, 2-chloroacetylchloride (1.2 mM) in 5 ml was added drop by drop 
for 10 min, then the reaction mixture was stirred at room temperature for about 2 h. Progress 
of the reaction was monitored by TLC using hexane:ethyl acetate (6:4) mixture as mobile 
phase. After the completion of reaction, the reaction mass was quenched in ice cold water 
and the product was extracted with diethyl ether. The organic layer was washed with brine 
solution followed by distilled water and dried briefly (Na2SO4) and the volatiles were 
removed in vacuo at <30 oC, the resulting brownish solid was identified. 
 Brownish solid, yield (85%), m.p. 185-188 ºC, IR (KBr) νmax (cm-1): 3349.75 (COOH), 
2926.60 (Ar-H), 1603.2 (C=O); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.0 (s, 1H, COOH), 
7.33 (s, 1H, CH of indole), 6.87-8.11 (m, 4H, Ar-H), 4.49 (s, 2H, CH2Cl); Mass (m/z): M+ 
238.02; Anal. Calcd. for C11H8ClNO3 : C, 55.60; H, 3.39; N, 5.89; O, 20.20%; Found; C, 
55.57; H, 3.43; N, 5.85; O, 20.24%. 
General procedure for the synthesis for the indole-2-carboxylic acid conjugated 
with aryl amine analogues (2a-k) 
A mixture of aryl amines (1.2 mM) and K2CO3 (1 mM) in dry tetrahydrofuran (dry THF,               
10 mL) were stirred under N2 atmosphere for 30 min at room temperature. The mixture was 
treated drop wise with 1-(2-chloroacetyl)-1H-indole-2-carboxylic acid (1 mM) in dry THF 
(10 mL) and refluxed for 4 h. The progress of the reaction was monitored by TLC. The 
reaction mixture was then desolventized in rotary evaporator and the product was extracted 
in ethyl acetate and washed with water and dried over anhydrous Na2SO4. The products were 
separated and purified by column chromatography, using hexane:ethyl acetate=60:40. 
1-(2-(Phenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2a) 
Brown solid, m.p. 137-139 oC, IR (KBr) νmax (cm-1): 3623.32 (COOH), 3330.46 (N-H), 
2854.17-2938.52 (Ar-H),1653.66 (C=O ); 1H NMR (400 MHz) (CDCl3) (δ ppm): 11.0       
(s, 1H, COOH), 7.1-8.11 (m, 9H, Ar-H), 7.33 (s, 1H, CH of indole), 4.17 (s, 2H, CH2N-H), 
4.0 (s, 1H, NH); 13C HMR (CDCl3) (δ ppm): 168.2, 160.1, 147.5, 141.1, 129.5, 127.4, 124.4, 
123.5, 120.8, 115.6, 53.1; Mass (m/z): M+ 295.3; Anal. Calcd. for  C17H14N2O3 : C, 69.38; H, 
4.79; N, 9.52; O, 16.31%; Found; C, 69.40; H, 4.81; N, 9.53; O, 16.30%. 
1-(2-(2-Hydroxyphenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2b) 
Light yellow solid, m.p. 157-159 oC, IR (KBr) νmax (cm-1): 3344.16 (COOH), 3316.12 (N-H), 
2853.51-2930.85 (Ar-H), 1605.40 (C=O ); 1H NMR (400 MHz) (CDCl3) (δ ppm): 11.2 (s, 1H, 
COOH), 7.23 (s, 1H, CH of indole), 6.83-8.20 (m, 8H, Ar-H), 5.35 (s, 1H, OH of Phenol), 4.3        
(s, 1H, NH), 4.15 (s, 2H, CH2N-H); 13C HMR (CDCl3) (δ ppm): 168.3, 160.1, 141.7, 140.9, 139.8, 
127.3, 124.4, 123.2, 120.0, 118.6, 114.8, 53.3; Mass (m/z): M+ 311.50; Anal. Calcd. for C17H14N2O4 
: C, 65.80; H, 4.55; N, 9.03; O, 20.62%; Found; C, 65.83; H, 4.52; N, 9.07; O, 20.60%. 
1-(2-(4-Hydroxyphenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2c) 
Yellow solid, m.p. 153-155 oC,IR (KBr) νmax (cm-1): 3622.63 (COOH), 3306.46 (N-H), 
2853.58-2923.56 (Ar-H), 1689.98 (C=O ); 1H NMR (400 MHz) (CDCl3) (δ ppm: 11.0            
(s, 1H, COOH), 7.4 (s, 1H, CH of indole), 6.92-8.11 (m, 8H, Ar-H), 5.42 (s, 1H, OH), 4.17 
(s, 2H, CH2N-H),), 4.0 (s, 1H, NH); 13C HMR (CDCl3) (δ ppm): 168.4, 160.2, 146.8, 141.1,  
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127.5, 126.6, 124.3, 119.5, 116.8, 115.8, 53.2; Mass (m/z): M+ 311.13; Anal. Calcd. for 
C17H14N2O4 : C, 65.80; H, 4.55; N, 9.03; O, 20.62%; Found; C, 65.83; H, 4.52; N, 9.06; O, 
20.60%. 
1-(2-(2-Methoxyphenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2d)  
Pale brown solid, m.p. 160-162 oC, IR (KBr) νmax (cm-1): 3394.32 (COOH), 3334.32 (N-H), 
2862.17-2938.52 (Ar-H), 1615.52 (C=O ); 1H NMR (400 MHz) (CDCl3) (δ ppm): 11.3 (s, 1H, 
COOH), 7.35 (s, 1H, CH of indole), 6.86-8.21 (m, 8H, Ar-H), 4.19 (s, 2H, CH2N-H), 4.0 (s, 1H, 
NH), 3.83 (s, 3H, OCH3); 13C HMR (CDCl3) (δ ppm): 168.3, 160.1, 144.6, 141.1, 128.3, 127.4, 
124.4, 123.6, 121.8, 119.6, 55.9, 53.1; Mass (m/z): M+ 325.01; Anal. Calcd. for  C18H16N2O4 : C, 
66.66; H, 4.97;   N, 8.64; O, 19.73%; Found; C, 66.68; H, 4.96; N, 8.61; O, 19.70%. 
1-(2-(4-Methoxyphenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2e) 
Pale brown semisolid, IR (KBr) νmax (cm-1): 3589.51 (COOH), 3316.16 (N-H), 2852.54-
2924.52 (Ar-H), 1630.88 (C=O ); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.0 (s, 1H, COOH), 
7.42 (s, 1H, CH of indole), 6.87-8.11(m, 8H, Ar-H), 4.27 (s, 2H, CH2N-H), 4.1 (s, 1H, NH), 
3.86 (s, 3H, OCH3); 13C HMR (CDCl3) (δ ppm): 168.2, 160.3, 151.6, 141.2, 139.6, 127.4, 
124.2,  123.5, 119.9, 55.9, 53.1; Mass (m/z): M+ 325.13; Anal. Calcd. for C18H16N2O4 : C, 
66.66; H, 4.97; N, 8.64; O, 19.73%; Found; C, 66.65; H, 4.99; N, 8.62; O, 19.71%. 
1-(2-(2,4-Dimethoxyphenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2f) 
Yellow semisolid, IR (KBr) νmax (cm-1): 3626.48 (COOH), 3334.46 (N-H), 2853.17-2924.52 
(Ar-H), 1687.66 (C=O ); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.0 (s, 1H, COOH), 7.85-
8.11 (m, 8H, Ar-H), 7.33 (s, 1H, CH of indole), 4.19 (s, 1H, NH), 4.12 (s, 2H, CH2N-H), 3.87 
(s, 6H, OCH3); 13C HMR (CDCl3) (δ ppm): 168.4, 162.3, 160.3, 145.6, 141.1, 130.7, 126.4, 
124.1, 119.8, 101.3,  55.8, 53.2; Mass (m/z): M+ 355.26; Anal. Calcd. for C19H18N2O5 : C, 
64.40; H, 5.12; N, 7.91; O, 22.58%; Found; C, 64.43; H, 5.13; N, 7.95; O, 22.54%. 
1-(2-(p-Tolylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2g)  
White solid, m.p. 167-169 oC, IR (KBr) νmax (cm-1): 3621.66 (COOH), 3340.16 (N-H), 
2854.13-2954.82 (Ar-H), 1618.95 (C=O ); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.6 (s, 1H, 
COOH), 7.13 (s, 1H, CH of indole), 7.0-8.11(m, 8H, Ar-H), 4.27 (s, 2H, CH2N-H), 4.1 (s, 1H, 
NH), 2.32 (s, 3H, CH3); 13C HMR (CDCl3) (δ ppm): 168.3, 160.2, 144.5, 141.2, 130.7, 126.8, 
124.3, 119.8, 113.2, 53.6, 21.4; Mass (m/z): M+ 309.06; Anal. Calcd. for C18H16N2O3 : C, 
70.12; H, 5.23; N, 9.09; O, 15.57%; Found; C, 70.15; H, 5.26; N, 9.07; O, 15.55%. 
1-(2-(4-Chlorophenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2h) 
Light brown solid, m.p. 143-145 oC, IR (KBr) νmax (cm-1): 3538.31 (COOH), 3309.16 (N-H), 
2853.17-2935.52 (Ar-H),1620.88 (C=O); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.1 (s, 1H, 
COOH), 6.87-8.11 (m, 8H, Ar-H), 7.33 (s, 1H, CH of indole), 4.18 (s, 2H, CH2N-H), 4.1          
(s, 1H, NH); 13C HMR (CDCl3) (δ ppm): 168.3, 145.7, 141.6, 129.6, 126.0, 124.2, 123.4, 
119.7, 114.8, 53.2; Mass (m/z): M+ 330.08; Anal. Calcd. for C17H13ClN2O3 : C, 62.11; H, 
3.99N, 8.52; O, 14.60%; Found; C, 62.13; H, 3.97; N, 8.56; O, 14.61%. 
1-(2-(4-Bromophenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2i) 
Brown solid, m.p. 138-140 oC, IR (KBr) νmax (cm-1): 3438.31 (COOH), 3312.96 (N-H), 
2848.17-2924.52 (Ar-H), 1618.95 (C=O ); 1H  NMR (400  MHz) (CDCl3) δ ppm): 11.2 (s, 1H, 
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COOH), 6.87-8.11 (m, 8H, Ar-H), 7.31 (s, 1H, CH of indole), 4.18 (s, 2H, CH2N-H), 4.0           
(s, 1H, NH); 13C HMR (CDCl3) (δ ppm): 168.2, 160.2, 146.5, 132.3, 126.4, 124.3, 119.7, 
115.0, 114.2, 53.1; Mass (m/z): M+ 373.06; Anal. Calcd. for C17H13BrN2O3 : C, 54.71; H, 
3.51; N, 7.51; O, 12.86%; Found; C, 54.73; H, 3.54; N, 7.48; O, 12.87%. 
1-(2-(2-Nhitrophenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2j)  
Pale yellow solid, m.p. 118-120 oC, IR (KB) νmax (cm-1): 3621.66 (COOH), 3353.60 (N-H), 
2854.13-2923.56 (Ar-H), 1625.70 (C=O ); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.6          
(s, 1H, COOH), 6.87-8.11 (m, 8H, Ar-H), 7.31 (s, 1H, CH of indole), 4.17 (s, 2H, CH2N-H), 
4.0 (s, 1H, NH); 13C HMR (CDCl3) (δ ppm): 168.2, 160.1, 145.4, 131.7, 135.4, 125.6, 124.2, 
123.5, 119.8, 108.6, 52.2; Mass (m/z): M+ 340.05; Anal. Calcd. for  C17H13N3O5 : C, 60.18; 
H, 3.86; N, 12.38; O, 23.58%; Found; C, 60.16; H, 3.85; N, 12.41; O, 23.59%. 
1-(2-(4-Nitrophenylamino)acetyl)-1H-indole-2-carboxylic acid (compound 2k) 
Pale yellow solid, m.p. 125-128 oC, IR (KBr) νmax (cm-1): 3478.95 (COOH), 3358.43 (N-H), 
2853.17-2924.52 (Ar-H), 1630.52 (C=O ); 1H NMR (400 MHz) (CDCl3) δ ppm): 11.0           
(s, 1H, COOH), 6.87-8.20 (m, 8H, Ar-H),), 7.30 (s, 1H, CH of indole), 4.17 (s, 2H, CH2N-H 
4.0 (s, 1H, NH); 13C HMR (CDCl3) (δ ppm): 168.4, 160.3, 153.8, 141.2, 136.2, 127.7, 126.5, 
123.5, 119.8, 114.3, 108.4, 53.1; Mass (m/z): M+ 341.20; Anal. Calcd. for C17H13N3O5 : C, 
60.18; H, 3.86; N, 12.38; O, 23.58%; Found; C, 60.19; H, 3.84; N, 12.36; O, 23.59%. 
Results and Discussion 
A series of novel indole-2-carboxylic acid derivatives (2a-k) were synthesized. Scheme 1 
and Scheme 2 illustrates the way used for the preparation of target molecules. The starting 
material, indole-2-carboxylic acid (1) reacts with chloroacetyl chloride in the presence of 
triethylamine as a base to yield 1-(2-chloroacetyl)-1H-indole-2-carboxylic acid (2), a key 
scaffold Scheme 1. Further, in order to assemble the key scaffold (2) and different aryl 
amines and to study the effect on antioxidant properties, the key scaffold (2) was 
conjugated with different aryl amines in the presence of potassium carbonate as a base to 
afford desired products (2a-k) Scheme 2. Structural conformation was done using IR, 1H 
NMR, 13C NMR, mass spectra and elemental analysis. In the IR spectrum of 1-(2-
chloroacetyl)-1H-indole-2-carboxylic acid (2) the C=O stretching band was observed at 
1603.2 cm-1 and absence of N-H band at 3310 cm-1 confirms the N-acylation reaction. The 
structure of the compound (2) was further confirmed by 1H NMR spectrum where the 
absence of the signal at δ 11.1 ppm which corresponds to N-H proton of indole ring. All 
the respective aromatic protons were signaled at δ 6.87–8.11 ppm. 1H NMR spectra of all 
indole-2-carboxylic acid aryl-amine conjugates (2a-k) showed multiplet for Ar–H proton 
at δ 6.76–8.11 ppm and singlet for N-H protons at δ 4.0-4.1 ppm. All the analogues 
showed mass according to their M+ ions. 
Antioxidant activities  
All the newly synthesized series of indole-2-carboxylic acid conjugated aryl-amine 
derivatives (2a-k) were screened for their antioxidant potential by employing different in 
vitro assays such as, DPPH free radical scavenging assay and 2,2'-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS•+) radical scavenging activity, ferric reducing 
antioxidant power, cupric ion reducing ability method and phosphomolybdate method. All 
the in vitro assay measurements were performed in triplicates. 
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DPPH free radical scavenging activity 
The newly synthesized compounds were screened for free radical scavenging activity by 
DPPH method18. DPPH is a stable nitrogen-centered free radical, the color of which changes 
from violet to yellow upon reduction by either the process of hydrogen or electron donation. 
The samples and the standards like butylated hydroxy anisole (BHA) and ascorbic acid were 
prepared at concentrations of 10, 25, 50, 100, 200 and 500 µM. Among the tested indole-2-
carboxylic acid conjugated with aryl amine analogues (2a-k) displayed certain degree of 
activity. The results of the analogues appeared to be related to the nature of the substituent 
group on the substituted phenyl ring of aryl amines. Among the synthesized analogues, 
compound 2c exhibited better scavenging activity (Table 2), this may be due to the presence 
of hydroxyl group on the para substituted phenyl ring. Chloro, bromo and nitro substituted 
indole-2-carboxylic acid derivatives (2h-k) showed least scavenging activities compared to 
standard. 
Table 1. Chemical structures and yields of indole-2-carboxylic acid aryl-amine conjugates 
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Table 2. Concentration required for 50% scavenging (IC50) of DPPH• and ABTS•+ radical 
scavenging activities of the compounds (2a-k) and the standard antioxidant compounds 
BHA and Ascorbic acid. Each value represents mean ± SD (n=3) 
Tested compounds Scavenging activity (IC50)
a 
DPPH• ABTS•+ 
BHA 12.2±0.12 20.9±0.12 
Ascorbic acid 11.1±0.11 18.3±0.14 
01 124±0.34 88.4±0.16 
2a 156±0.21 132.1±0.35 
2b 18±0.25 36.6±0.24 
2c 15±0.63 29.3±0.45 
2d 81±0.62 153.16±0.81 
2e 61±0.54 132.62±0.35 
2f 26±0.20 32.7±0.12 
2g 132±0.51 189.03±0.33 
2h 189±0.11 173.12±0.10 
2i 301±0.72 350.85±0.53 
2j 234±0.45 203.34±0.60 
2k 261±0.16 293.32±0.27 
aThe values are expressed as µM concentration. Lower IC50 values indicate higher radical scavenging 
activity 
ABTS•+ radical scavenging activity 
The synthesized indole-2-carboxylic acid aryl-amine conjugates were subjected to ABTS•+ 
radical scavenging activity19. This assay is based on a decolorization technique in which 
the radical is generated directly in a stable form prior to reaction with putative 
antioxidants. In this assay, the technique is based on the direct production of the 
blue/green ABTS•+ chromophore through the reaction between ABTS and potassium 
persulfate. Amongst the synthesized analogues, compounds 2c, 2b and 2f showed 
promising ABTS•+ scavenging activity and compounds 2g, 2e and 2d displayed moderate 
scavenging activity. Whereas, compounds 2h, 2i, 2j and 2k possessing chloro and nitro 
substituents showed very least ABTS•+ scavenging activity compared to standard BHA 
and ascorbic acid (Table 2). 
Ferric reducing antioxidant power (FRAP) assay 
All the synthesized indole-2-carboxylic acid aryl-amine conjugates were screened for ferric 
reducing antioxidant power20. The FRAP method is based on the reduction of Fe3+-Fe2+. The 
presence of antioxidants in the samples would result in the reducing Fe3+ to Fe2+ by donating 
an electron. The amount of Fe2+ complex can be then monitored by measuring the formation 
of Prussian blue at 700 nm. The reducing ability of the compound may serve as a significant 
indicator of its potential antioxidant activity. Compounds 2b, 2f, 2d and 2e displayed good 
ferric ion reducing ability compared to other scaffolds. Compound 2c has the most powerful 
ferric ion reducing ability, this may be due to the electron donating power of hydroxy group 
present in the substituted phenyl ring. Also the results from the (Table 3) reveals that the 
presence of electron withdrawing groups on the substituted phenyl ring did not favors in the 
ferric ion reducing ability. 
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Table 3. Comparison of ferric ions (Fe3+) reducing ability by Fe3+-Fe2+ transformation 
methods, Cu2+-Cu+ reducing ability and phosphomolybdenum method of the compounds 







Phosphomolybdenum   
assayb 
BHA 0.3490 0.3130 372.71 
Ascorbic acid 0.4013 0.3612 388.12 
01 0.1272 0.1420 93.48 
2a 0.1272 0.1063 111.27 
2b 0.3079 0.2897 282.16 
2c 0.3324 0.3006 348.67 
2d 0.2709 0.2513 276.17 
2e 0.2681 0.2486 307.22 
2f 0.2953 0.1953 294.22 
2g 0.1536 0.1411 101.14 
2h 0.1163 0.0931 83.87 
2i 0.0615 0.0791 78.24 
2j 0.0961 0.0061 70.97 
2k 0.0817 0.1040 101.90 
aThe values are expressed as absorbance. High absorbance indicates high reducing power.             
bThe values are expressed as equivalent of Ascorbic acid (µM/mg) 
Cupric ion reducing ability 
All the synthesized compounds were performed cupric ion reducing ability assay21. This 
method utilizes the copper(II)-neocuproine reagent as the chromogenic oxidizing agent. This 
reagent was useful at pH 7 and the absorbance of the Cu(I)-chelate formed as a result of 
redox reaction with the samples was measured at 450 nm. Among the synthesized 
derivatives, compounds 2c, 2b, 2e and 2d exhibited the marked cupric ion reducing ability. 
All other indole-2-carboxylic acid aryl-amine conjugates such as 2f and 2a showed moderate 
cupric reducing activity. The results are showed in (Table 3).  
Phosphomolybdenum method 
The antioxidant activity for the synthesized compounds (2a-k) was evaluated by using 
phosphomolybdate method22. It determines the total antioxidant capacity. This assay is based 
on the reduction of Mo(VI) to Mo(V) in presence of the antioxidant compounds and the 
subsequent formation of a green phosphate Mo(V) complex at acidic pH, which is measured 
at 695 nm. The antioxidant capacity of the compounds was determined for 10 μM 
concentration. Among the synthesized analogues compound 2c, 2e, 2f, 2b and 2d displayed 
good reducing ability of Mo(VI) to Mo(V) in better way due to the presence of electron 
donating groups such as hydroxy and methoxy in the substituted phenyl ring. 
Antioxidant activities 
DPPH Free radical scavenging activity 
The newly synthesized compounds were screened for free radical scavenging activity by 
DPPH method18. Compounds of different concentrations were prepared in distilled ethanol, 
1 mL of each compound solutions (2a-k) having different concentrations (10, 25, 50, 100, 200 
and 500 µM) were taken in different test tubes, 4 mL of 0.1 mM ethanol solution of DPPH was 
added and shaken vigorously. The test tubes were  then incubated  in the dark room at r.t.  
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for 20 min. A DPPH blank was prepared without the compound and ethanol was used for the 
baseline correction. Changes (decrease) in the absorbance at 517 nm were measured using a 
UV-visible spectrometer (Shimadzu 160 A). The radical scavenging activities were 
expressed as the inhibition percentage and were calculated using the formula: 
Radical scavenging activity (%) = [(Ac-As)/Ac)x100] 
 Where Ac is absorbance of the control (without compound) and As is absorbance of the 
compounds (2a-k). The radical scavenging activity of BHA and ascorbic acid was also 
measured and compared with that of the different synthesized compound. The compound 
concentration providing 50% inhibition (IC50) was calculated from the graph of RSA 
percentage against compound concentrations. 
ABTS•+ radical scavenging activity 
The analysis of ABTS•+ radical scavenging activity was determined according to Re 
method19. The ABTS•+ cation was produced by the reaction between 7 mM ABTS in H2O 
and 2.45 mM potassium persulfate, stored in the dark at room temperature for 12 h. Before 
the usage, the ABTS•+ solution was diluted to get an absorbance of 0.700±0.025 at 734 nm 
with phosphate buffer (0.1M, pH 7.4). Then, 1 mL of ABTS•+ solution was added to the 
1.5 mL compounds (2a-k) solution in ethanol at different concentrations (10, 25, 50, 100, 
200 and 500 µM/mL). After 30 min, the percentage inhibition at 734 nm was calculated for 
each concentration relative to a blank absorbance (ethanol).  
The scavenging capability of ABTS•+ radical was calculated using the following equation: 
ABTS•+ scavenging effect (%) = [(Ac-As) / Ac] x 100 
 Where, Acontrol is the initial concentration of the ABTS•+ and Asample is the absorbance of 
the remaining concentration of ABTS•+ in the presence of the compounds (2a-k). 
Ferric ion (Fe3+) reducing antioxidant power assay 
The reducing antioxidant power assay for the newly synthesized compounds was determined 
according to Oyaizu method20. 2 mL of the compounds (2a-k) having concentration 10 µM 
were mixed with phosphate buffer (2.5 ml, 0.2 M, pH 6.6) and potassium ferric cyanide         
(2.5 mL, 1%). The mixture was incubated at 50 oC for 20 min. Later, the reaction mixture 
was acidified with trichloroacetic acid (2.5 mL, 10%). After FeCl3 (0.5 mL, 0.1%) was 
added to this solution, the absorbance was measured at 700 nm. The increased absorbance of 
the reaction mixture indicates an increased reducing power.  
Cupric ion (Cu2+) reducing ability:  
The cupric reducing ability antioxidant assay was determined according to the literature 
method21. Briefly, a mixture of CuCl2 (1 mL, 0.01 M)  solution, ethanolic neocuproine (Nc) 
(1 mL, 7.5x10-3 M) solution and Ammonium acetate (1 mL, 1 M) in a test tube were added 
to a solution of compounds (2a-k) having 10 µM concentration along with 0.1 mL distilled 
water. The mixture was incubated for 30 min. Then the absorbance was measured at 450 nm 
against reagent blank. 
Evaluation of antioxidant capacity by Phosphomolybdenum method 
The total antioxidant capacity was evaluated by the reported method22. An aliquot of 0.1 mL 
of compound solutions (10 μM) was combined with 1 mL of reagent solution (0.6 M sulfuric 
acid, 28 mM sodium phosphate and 4 mM ammonium molybdate). In case of blank 0.1 mL 
of methanol was used in place of compound. The  tubes were  capped and incubated in a  
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boiling water bath at 95 oC for 90 min. After the samples had cooled to room temperature, 
the absorbance of the aqueous solution of each was measured at 695 nm against blank of 
spectrophotometer. The antioxidant capacities of the synthesized indole-2-carboxylic acid 
analogues (2a-k) were expressed as equivalent of ascorbic acid (μM/mg of compound). 
Conclusion 
In conclusion, we have synthesized a new series of indole-2-carboxylic acid conjugated with 
aryl amines (2a-k) and evaluated for their antioxidant power by various in vitro methods. 
Most of them demonstrated a broad spectrum of antioxidant activities. The simple indole-2-
carboxylic acid derivatives 2b, 2d, 2e and 2f were concluded as good antioxidant activity, 
whereas 2c displayed more potent derivative in all the in vitro antioxidant assays. It clearly 
demonstrated that the assembly of appropriate aryl-amine substituents on the N-acylated 
indole-2-carboxylic acid moiety would lead to the enhancement for potent antioxidant 
derivatives. It implied that, compounds 2c, 2b, 2d, 2e and 2f may be considered as new 
promising lead candidates for further design and synthesis of this class of  antioxidants.  
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